Cargando…
Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
BACKGROUND: Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain caus...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820939/ https://www.ncbi.nlm.nih.gov/pubmed/27044414 http://dx.doi.org/10.1186/s12916-016-0602-x |
_version_ | 1782425500679929856 |
---|---|
author | Bonilla, Carolina Lewis, Sarah J. Martin, Richard M. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Eeles, Rosalind Easton, Doug Kote-Jarai, Zsofia Al Olama, Ali Amin Benlloch, Sara Muir, Kenneth Giles, Graham G. Wiklund, Fredrik Gronberg, Henrik Haiman, Christopher A. Schleutker, Johanna Nordestgaard, Børge G. Travis, Ruth C. Pashayan, Nora Khaw, Kay-Tee Stanford, Janet L. Blot, William J. Thibodeau, Stephen Maier, Christiane Kibel, Adam S. Cybulski, Cezary Cannon-Albright, Lisa Brenner, Hermann Park, Jong Kaneva, Radka Batra, Jyotsna Teixeira, Manuel R. Pandha, Hardev Lathrop, Mark Davey Smith, George |
author_facet | Bonilla, Carolina Lewis, Sarah J. Martin, Richard M. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Eeles, Rosalind Easton, Doug Kote-Jarai, Zsofia Al Olama, Ali Amin Benlloch, Sara Muir, Kenneth Giles, Graham G. Wiklund, Fredrik Gronberg, Henrik Haiman, Christopher A. Schleutker, Johanna Nordestgaard, Børge G. Travis, Ruth C. Pashayan, Nora Khaw, Kay-Tee Stanford, Janet L. Blot, William J. Thibodeau, Stephen Maier, Christiane Kibel, Adam S. Cybulski, Cezary Cannon-Albright, Lisa Brenner, Hermann Park, Jong Kaneva, Radka Batra, Jyotsna Teixeira, Manuel R. Pandha, Hardev Lathrop, Mark Davey Smith, George |
author_sort | Bonilla, Carolina |
collection | PubMed |
description | BACKGROUND: Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain causal estimates, we examined the role of pubertal development in prostate cancer using genetic polymorphisms associated with Tanner stage in adolescent boys in a Mendelian randomization (MR) approach. METHODS: We derived a weighted genetic risk score for pubertal development, combining 13 SNPs associated with male Tanner stage. A higher score indicated a later puberty onset. We examined the association of this score with prostate cancer risk, stage and grade in the UK-based ProtecT case-control study (n = 2,927), and used the PRACTICAL consortium (n = 43,737) as a replication sample. RESULTS: In ProtecT, the puberty genetic score was inversely associated with prostate cancer grade (odds ratio (OR) of high- vs. low-grade cancer, per tertile of the score: 0.76; 95 % CI, 0.64–0.89). In an instrumental variable estimation of the causal OR, later physical development in adolescence (equivalent to a difference of one Tanner stage between pubertal boys of the same age) was associated with a 77 % (95 % CI, 43–91 %) reduced odds of high Gleason prostate cancer. In PRACTICAL, the puberty genetic score was associated with prostate cancer stage (OR of advanced vs. localized cancer, per tertile: 0.95; 95 % CI, 0.91–1.00) and prostate cancer-specific mortality (hazard ratio amongst cases, per tertile: 0.94; 95 % CI, 0.90–0.98), but not with disease grade. CONCLUSIONS: Older age at sexual maturation is causally linked to a reduced risk of later prostate cancer, especially aggressive disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0602-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4820939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48209392016-04-06 Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort Bonilla, Carolina Lewis, Sarah J. Martin, Richard M. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Eeles, Rosalind Easton, Doug Kote-Jarai, Zsofia Al Olama, Ali Amin Benlloch, Sara Muir, Kenneth Giles, Graham G. Wiklund, Fredrik Gronberg, Henrik Haiman, Christopher A. Schleutker, Johanna Nordestgaard, Børge G. Travis, Ruth C. Pashayan, Nora Khaw, Kay-Tee Stanford, Janet L. Blot, William J. Thibodeau, Stephen Maier, Christiane Kibel, Adam S. Cybulski, Cezary Cannon-Albright, Lisa Brenner, Hermann Park, Jong Kaneva, Radka Batra, Jyotsna Teixeira, Manuel R. Pandha, Hardev Lathrop, Mark Davey Smith, George BMC Med Research Article BACKGROUND: Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain causal estimates, we examined the role of pubertal development in prostate cancer using genetic polymorphisms associated with Tanner stage in adolescent boys in a Mendelian randomization (MR) approach. METHODS: We derived a weighted genetic risk score for pubertal development, combining 13 SNPs associated with male Tanner stage. A higher score indicated a later puberty onset. We examined the association of this score with prostate cancer risk, stage and grade in the UK-based ProtecT case-control study (n = 2,927), and used the PRACTICAL consortium (n = 43,737) as a replication sample. RESULTS: In ProtecT, the puberty genetic score was inversely associated with prostate cancer grade (odds ratio (OR) of high- vs. low-grade cancer, per tertile of the score: 0.76; 95 % CI, 0.64–0.89). In an instrumental variable estimation of the causal OR, later physical development in adolescence (equivalent to a difference of one Tanner stage between pubertal boys of the same age) was associated with a 77 % (95 % CI, 43–91 %) reduced odds of high Gleason prostate cancer. In PRACTICAL, the puberty genetic score was associated with prostate cancer stage (OR of advanced vs. localized cancer, per tertile: 0.95; 95 % CI, 0.91–1.00) and prostate cancer-specific mortality (hazard ratio amongst cases, per tertile: 0.94; 95 % CI, 0.90–0.98), but not with disease grade. CONCLUSIONS: Older age at sexual maturation is causally linked to a reduced risk of later prostate cancer, especially aggressive disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0602-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-04 /pmc/articles/PMC4820939/ /pubmed/27044414 http://dx.doi.org/10.1186/s12916-016-0602-x Text en © Bonilla et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Bonilla, Carolina Lewis, Sarah J. Martin, Richard M. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Eeles, Rosalind Easton, Doug Kote-Jarai, Zsofia Al Olama, Ali Amin Benlloch, Sara Muir, Kenneth Giles, Graham G. Wiklund, Fredrik Gronberg, Henrik Haiman, Christopher A. Schleutker, Johanna Nordestgaard, Børge G. Travis, Ruth C. Pashayan, Nora Khaw, Kay-Tee Stanford, Janet L. Blot, William J. Thibodeau, Stephen Maier, Christiane Kibel, Adam S. Cybulski, Cezary Cannon-Albright, Lisa Brenner, Hermann Park, Jong Kaneva, Radka Batra, Jyotsna Teixeira, Manuel R. Pandha, Hardev Lathrop, Mark Davey Smith, George Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
title | Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
title_full | Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
title_fullStr | Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
title_full_unstemmed | Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
title_short | Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort |
title_sort | pubertal development and prostate cancer risk: mendelian randomization study in a population-based cohort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820939/ https://www.ncbi.nlm.nih.gov/pubmed/27044414 http://dx.doi.org/10.1186/s12916-016-0602-x |
work_keys_str_mv | AT bonillacarolina pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT lewissarahj pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT martinrichardm pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT donovanjennyl pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT hamdyfreddiec pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT nealdavide pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT eelesrosalind pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT eastondoug pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT kotejaraizsofia pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT alolamaaliamin pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT benllochsara pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT muirkenneth pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT gilesgrahamg pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT wiklundfredrik pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT gronberghenrik pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT haimanchristophera pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT schleutkerjohanna pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT nordestgaardbørgeg pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT travisruthc pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT pashayannora pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT khawkaytee pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT stanfordjanetl pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT blotwilliamj pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT thibodeaustephen pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT maierchristiane pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT kibeladams pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT cybulskicezary pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT cannonalbrightlisa pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT brennerhermann pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT parkjong pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT kanevaradka pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT batrajyotsna pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT teixeiramanuelr pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT pandhahardev pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT lathropmark pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT daveysmithgeorge pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort AT pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort |